tibljТуберкулез и болезни легкихTuberculosis and Lung Diseases2075-12302542-1506Медицинские знания и технологии10.21292/2075-1230-2022-100-3-13-17tiblj-1619Research ArticleCOVID-19COVID-19Туберкулез и COVID-19: медицинские и социальные аспектыTuberculosis and COVID-19: Medical and Social AspectsСавинцеваЕ. В.SavintsevaE. V.

Савинцева Елена Валерьевна, ассистент кафедры

426039, г. Ижевск, Cлавянское шоссе, д. 0/1

Elena V. Savintseva, Assistant of Department

0/1, Slavyanskoye Rd, Razyan, 426039

olegr22@mail.ruИсаеваП. В.IsaevaP. V.

Исаева Полина Владимировна, студентка 6-го курса лечебного факультета

426039, г. Ижевск, Cлавянское шоссе, д. 0/1

Polina V. Isaeva, Student of the VIth Year of Training, General Medicine Department

0/1, Slavyanskoye Rd, Razyan, 426039

polina.polina.isaeva.1997.isaev@mail.ruНизамоваГ. Ф.NizamovaG. F.

Низамова Гузалия Фирузовна, студентка 6-го курса лечебного факультета

426039, г. Ижевск, Cлавянское шоссе, д. 0/1

Guzaliya F. Nizamova, Student of the VIth Year of Training, General Medicine Department

0/1, Slavyanskoye Rd, Razyan, 426039

nizamova.guzalia@yandex.ruФГБОУ ВО «Ижевская государственная медицинская академия» МЗ РФРоссияIzhevsk State Medical AcademyRussian Federation20220604202210031317Copyright © Савинцева Е.В., Исаева П.В., Низамова Г.Ф., 20222022Савинцева Е.В., Исаева П.В., Низамова Г.Ф.Savintseva E.V., Isaeva P.V., Nizamova G.F.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tibl-journal.com/jour/article/view/1619

В обзоре рассмотрены данные из 28 источников литературы о взаимном влиянии COVID-19 и туберкулеза. Описываются диагностика, клинические проявления при сочетании заболеваний. Обсуждается социальное влияние самоизоляции и ограничительных мер, принятых в пандемию COVID-19, на лечение туберкулеза. Обсуждены сведения о влиянии БЦЖ на иммунный ответ при коронавирусе.

The review considers data from 28 publications devoted to the specific impact of COVID-19 on the course of tuberculosis. It describes diagnosis and clinical manifestations in case of co-infection of these two diseases. Also, it discusses the social impact of lockdowns and restrictive measures taken during the COVID-19 pandemic on the treatment of tuberculosis. The article discusses the impact of BCG vaccination on the immune response to the coronavirus.

COVID-19туберкулезвакцина BCGCOVID-19tuberculosisBCG vaccineReferencesВОЗ. Информационный бюллетень. Март 2021 // Социальные аспекты здоровья населения. ‒ 2021. ‒ № 2 (67). ‒ С. 19.WHO. Information Bulletin. March 2021. Sotsialnye Aspekty Zdorovya Naseleniya, 2021, no. 2 (67), pp. 19. (In Russ.)Екатеринчева О. Л., Малкова А. М., Карев В. Е., Кудрявцев И. В., Зинченко Ю. С., Потепун Т. Б., Кудлай Д. А., Старшинова А. А. Особенности диагностики туберкулеза на фоне COVID-19 // Журнал инфектологии. ‒ 2021. ‒ Т. 13, № 1. ‒ С. 117-123.Ekaterincheva O.L., Malkova А.M., Karev V.E., Kudryavtsev I.V., Zinchenko Yu.S., Potepun T.B., Kudlay D.А., Starshinova А.А. Specific parameters of tuberculosis diagnostics in case of concurrent COVID-19. Journal Infektologii, 2021, vol. 13, no. 1, pp. 117-123. (In Russ.)Шварц Я. Ш., Ставицкая Н. В., Кудлай Д. А. BCG-вакцинирование как протекция от COVID-19: эпидемиологические и молекулярно-биологические аспекты // Туб. и болезни легких. ‒ 2020. ‒ Т. 98, № 5. ‒ С. 6-14.Shvarts Ya.Sh., Stavitskaya N.V., Kudlay D.А. BCG vaccination as protection from COVID-19: epidemiological and molecular biological aspects. Tuberculosis and Lung Diseases, 2020, vol. 98, no. 5, pp. 6-14. (In Russ.)Ahmed S. M., Nasr M. A., Elshenawy S. E., Hussein A. E., El-Betar A. H., Mohamed R. H., El-Badri N. BCG vaccination and the risk of COVID 19: A possible correlation // Virology. ‒ 2022. ‒ Vol. 565. ‒ P. 73-81. https://doi.org/10.1016/j.virol.2021.10.003.Ahmed S.M., Nasr M.A., Elshenawy S.E., Hussein A.E., El-Betar A.H., Mohamed R.H., El-Badri N. BCG vaccination and the risk of COVID 19: A possible correlation. Virology, 2022, vol. 565, pp. 73-81. https://doi.org/10.1016/j.virol.2021.10.003.Amimo F., Lambert B., Magit A. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? // Trop. Med. Health. ‒ 2020. ‒ № 48. ‒ P. 32. https://doi.org/10.1186/s41182-020-00219-6.Amimo F., Lambert B., Magit A. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? Trop. Med. Health, 2020, no. 48, pp. 32. https://doi.org/10.1186/s41182-020-00219-6.Aspatwar A., Gong W., Wang S., Wu X., Parkkila S. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic // Intern. Rev. Immunol. – 2022. – Vol. 41, № 2. – P. 283-296. https://doi.org/10.1080/08830185.2021.1922685.Aspatwar A., Gong W., Wang S., Wu X., Parkkila S. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic. Intern. Rev. Immunol., 2022, vol. 41, no. 2, pp. 283-296. https://doi.org/10.1080/08830185.2021.1922685.Bagheri N., Montazeri H. On BCG Vaccine Protection from COVID-19: A Review // SN Compr. Clin. Med. ‒ 2021. ‒ № 3. ‒ P. 1-11. https://doi.org/10.1007/s42399-021-00835-1.Bagheri N., Montazeri H. On BCG Vaccine Protection from COVID-19: A Review. SN Compr. Clin. Med., 2021, no. 3, pp. 1-11. https://doi.org/10.1007/s42399-021-00835-1.Chen Y., Wang Y., Fleming J., Yu Y., Gu Y., Liu C., Fan L., Wang X., Cheng M., Bi L., Liu Y. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity // MedRxiv. – 2020. https://doi.org/10.1101/2020.03.Chen Y., Wang Y., Fleming J., Yu Y., Gu Y., Liu C., Fan L., Wang X., Cheng M., Bi L., Liu Y. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedRxiv, 2020. https://doi.org/10.1101/2020.03.Chopra K. K., Arora V. K., Singh S. COVID 19 and tuberculosis // Indian J. Tuberc. – 2020. – Vol. 67, № 2. – P. 149-151. https://doi.org/10.1016/j.ijtb.2020.06.001. 2020.Chopra K.K., Arora V.K., Singh S. COVID 19 and tuberculosis. Indian J. Tuberc., 2020, vol. 67, no. 2, pp. 149-151. https://doi.org/10.1016/j.ijtb.2020.06.001. 2020.Crisan-Dabija R., Grigorescu C., Pavel C. A., Artene B., Popa I. V., Cernomaz A., Burlacu A. Tuberculosis and COVID-19: Lessons from the past viral outbreaks and possible future outcomes // Can. Respir. J. – 2020. ‒ Vol. 2020. ‒ P. 1401053. https://doi.org/10.1155/2020/1401053.Crisan-Dabija R., Grigorescu C., Pavel C.A., Artene B., Popa I.V., Cernomaz A., Burlacu A. Tuberculosis and COVID-19: Lessons from the past viral outbreaks and possible future outcomes. Can. Respir. J., 2020, vol. 2020, pp. 1401053. https://doi.org/10.1155/2020/1401053.Davies M. HIV and risk of COVID-19 death: a population cohort study from the // Western Cape Province, South Africa // The preprint server for health sciences. – 2020. ‒ № 3. https://doi.org/10.1101/2020.07.02.20145185.Davies M. HIV and risk of COVID-19 death: a population cohort study from the. Western Cape Province, South Africa. The preprint server for health sciences. 2020, no. 3. https://doi.org/10.1101/2020.07.02.20145185.Diao B., Wang C., Tan Y., Chen X., Liu Y., Ning L., Chen L., Li M., Liu Y., Wang G., Yuan Z., Feng Z., Zhang Y., Wu Y., Chen Y. Reduction and functional exhaustion of T cells in patients with Coronavirus Disease 2019 (COVID-19) // Front. Immunol. ‒ 2020. ‒ Vol. 11. ‒ P. 827. https://doi.org/10.3389/fimmu.2020.00827.Diao B., Wang C., Tan Y., Chen X., Liu Y., Ning L., Chen L., Li M., Liu Y., Wang G., Yuan Z., Feng Z., Zhang Y., Wu Y., Chen Y. Reduction and functional exhaustion of T cells in patients with Coronavirus Disease 2019 (COVID-19). Front. Immunol., 2020, vol. 11, pp. 827. https://doi.org/10.3389/fimmu.2020.00827.Etna M. P., Giacomini E., Severa M., Coccia E. M. Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis // Semin. Immunol. – 2014. – Vol. 26, № 6. – P. 543-551. https://doi.org/10.1016/j.smim.2014.09.011.Etna M.P., Giacomini E., Severa M., Coccia E.M. Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis. Semin. Immunol., 2014, vol. 26, no. 6, pp. 543-551. https://doi.org/10.1016/j.smim.2014.09.011.Gao Y., Liu M., Chen Y., Shi S., Geng J., Tian J. Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis // J. Med. Virol. ‒ 2021. ‒ Vol. 93, № 1. ‒ P. 194-196. https://doi.org/10.1002/jmv.26311.Gao Y., Liu M., Chen Y., Shi S., Geng J., Tian J. Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis. J. Med. Virol., 2021, vol. 93, no. 1, pp. 194-196. https://doi.org/10.1002/jmv.26311.Iyengar K. P., Jain V. K. Tuberculosis and COVID-19 in India- double trouble! // Indian J. Tuberc. – 2020. – № 67 (4S). – Р. 175-176. https://doi.org/10.1016/j.ijtb.2020.07.014.Iyengar K.P., Jain V.K. Tuberculosis and COVID-19 in India- double trouble! Indian J. Tuberc., 2020, no. 67 (4S), pp. 175-176. https://doi.org/10.1016/j.ijtb.2020.07.014.Koupaei M., Naimi A., Moafi N., Mohammadi P., Tabatabaei F. S., Ghazizadeh S., Heidary M., Khoshnood S. Clinical characteristics, diagnosis, treatment, and mortality rate of TB/COVID-19 coinfectetd patients: A systematic review // Front. Med. (Lausanne). ‒ 2021. ‒ Vol. 8. ‒ P. 740593. https://doi.org/10.3389/fmed.2021.740593.Koupaei M., Naimi A., Moafi N., Mohammadi P., Tabatabaei F.S., Ghazizadeh S., Heidary M., Khoshnood S. Clinical characteristics, diagnosis, treatment, and mortality rate of TB/COVID-19 coinfectetd patients: A systematic review. Front. Med. (Lausanne), 2021, vol. 8, pp. 740593. https://doi.org/10.3389/fmed.2021.740593.Mack U., Migliori G. B., Sester M., Rieder H. L., Ehlers S., Goletti D., Bossink A., Magdorf K., Hölscher C., Kampmann B., Arend S. M., Detjen A., Both G., Zellweger J. P., Milburn H., Diel R., Ravn P., Cobelens F., Cardona P. J., Kan B. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement // Eur. Respir. J. – 2009. – Vol. 33. – № 5. – Р. 956-973. https://doi.org/10.1183/09031936.00120908.Mack U., Migliori G.B., Sester M., Rieder H.L., Ehlers S., Goletti D., Bossink A., Magdorf K., Hölscher C., Kampmann B., Arend S.M., Detjen A., Both G., Zellweger J.P., Milburn H., Diel R., Ravn P., Cobelens F., Cardona P.J., Kan B. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J., 2009, vol. 33, no. 5, pp. 956-973. https://doi.org/10.1183/09031936.00120908.Marwah V., Peter D. K., Ajai Kumar T., Bhati G., Kumar A. Multidrug-resistant tuberculosis in COVID-19: Double trouble // Med. J. Armed Forces India. – 2021. – № 77. – Р. 479-482. https://doi.org/10.1016/j.mjafi.2021.05.002.Marwah V., Peter D.K., Ajai Kumar T., Bhati G., Kumar A. Multidrug-resistant tuberculosis in COVID-19: Double trouble. Med. J. Armed Forces India, 2021, no. 77, pp. 479-482. https://doi.org/10.1016/j.mjafi.2021.05.002.Morrison A. L., Sharpe S., White A. D., Bodman-Smith M. Cheap and commonplace: making the case for BCG and γδ T cells in COVID-19 // Front. Immunol. ‒ 2021. ‒ Vol. 12. ‒ P. 743924. Published 2021 https://doi.org/10.3389/fimmu.2021.743924.Morrison A.L., Sharpe S., White A.D., Bodman-Smith M. Cheap and commonplace: making the case for BCG and γδ T cells in COVID-19. Front. Immunol., 2021, vol. 12, pp. 743924. Published 2021 https://doi.org/10.3389/fimmu.2021.743924.Mousquer G. T., Peres A., Fiegenbaum M. Pathology of TB/COVID-19 Co-Infection: The phantom menace // Tuberculosis. – 2021. – № 126. https://doi.org/10.1016/j.tube.2020.102020.Mousquer G.T., Peres A., Fiegenbaum M. Pathology of TB/COVID-19 Co-Infection: The phantom menace. Tuberculosis, 2021, no. 126. https://doi.org/10.1016/j.tube.2020.102020.Ręka G., Korzeniowska A., Piecewicz-Szczęsna H. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin (BCG) vaccine on COVID-19 incidence and mortality ‒ review of the literature // Przegl. Epidemiol. – Vol. 8, № 2. – P. 290-302. https://doi.org/10.32394/pe.74.22.Ręka G., Korzeniowska A., Piecewicz-Szczęsna H. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin (BCG) vaccine on COVID-19 incidence and mortality ‒ review of the literature. Przegl. Epidemiol., vol. 8, no. 2, pp. 290-302. https://doi.org/10.32394/pe.74.22.Ritacco V., Kantor I. N. Tuberculosis and COVID-19: a dangerous relationship. Tuberculosis y COVID-19: Una relación peligrosa // Medicina. – № 80. – S. 6. – Р. 117-118.Ritacco V., Kantor I.N. Tuberculosis and COVID-19: a dangerous relationship. Tuberculosis y COVID-19: Una relación peligrosa. Medicina, no. 80, s. 6, pp. 117-118.Shen H., Chen Z. W. The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection // Cell. Mol. Immunol. – 2018. – Vol. 15, №. 3. – P. 216-225. https://doi.org/10.1038/cmi.2017.128.Shen H., Chen Z.W. The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection. Cell. Mol. Immunol., 2018, vol. 15, no. 3, pp. 216-225. https://doi.org/10.1038/cmi.2017.128.Stochino C., Villa S., Zucchi P., Parravicini P., Gori A., Raviglione M. C. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital // Eur. Respir. J. – 2020. – Vol. 56, № 1. https://doi.org/10.1183/13993003.01708-2020.Stochino C., Villa S., Zucchi P., Parravicini P., Gori A., Raviglione M.C. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur. Respir. J., 2020, vol. 56, no. 1. https://doi.org/10.1183/13993003.01708-2020.Sy K. T. L., Haw N. J. L., Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19 // Infect. Dis. (Lond). – 2020. – Vol. 52, № 12. – P. 902-907. https://doi.org/10.1080/23744235.2020.180635332808838.Sy K.T.L., Haw N.J.L., Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect. Dis. (Lond.), 2020, vol. 52, no. 12, pp. 902-907. https://doi.org/10.1080/23744235.2020.180635332808838.Tadolini M., Codecasa L. R., García-García J. M., Blanc F. X., Borisov S., Alffenaar J. W., Andréjak C., Bachez P., Bart P. A., Belilovski E., Cardoso-Landivar J., Centis R., D'Ambrosio L., De Souza-Galvão M. L., Dominguez-Castellano A., Dourmane S., Fréchet Jachym M., Froissart A., Giacomet V., Goletti D., Grard S., Gualano G., Izadifar A., Le Du D., Royo M., Mazza-Stalder J., Motta I., Ong CWM, Palmieri F., Rivière F., Rodrigo T., Silva D. R., Sánchez-Montalvá A., Saporiti M., Scarpellini P., Schlemmer F., Spanevello A., Sumarokova E., Tabernero E., Tambyah P. A., Tiberi S., Torre A., Visca D., Zabaleta Murguiondo M., Sotgiu G., Migliori G. B. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases // Eur. Respir. J. – 2020. – Vol. 56, № 1. https://doi.org/10.1183/13993003.01398-2020.Tadolini M., Codecasa L.R., García-García J.M., Blanc F.X., Borisov S., Alffenaar J.W., Andréjak C., Bachez P., Bart P. A., Belilovski E., Cardoso-Landivar J., Centis R., D'Ambrosio L., De Souza-Galvão M.L., Dominguez-Castellano A., Dourmane S., Fréchet Jachym M., Froissart A., Giacomet V., Goletti D., Grard S., Gualano G., Izadifar A., Le Du D., Royo M., Mazza-Stalder J., Motta I., Ong CWM, Palmieri F., Rivière F., Rodrigo T., Silva D.R., Sánchez-Montalvá A., Saporiti M., Scarpellini P., Schlemmer F., Spanevello A., Sumarokova E., Tabernero E., Tambyah P.A., Tiberi S., Torre A., Visca D., Zabaleta Murguiondo M., Sotgiu G., Migliori G.B. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur. Respir. J., 2020, vol. 56, no. 1. https://doi.org/10.1183/13993003.01398-2020.Torun S., Ozkaya S., Şen N., Kanat F., Karaman I., Yosunkaya S., Sengoren Dikis O., Asan A., Aydogan Eroglu S., Semih Atal S., Ayten O., Aksel N., Ermiş H., Özçelik N., Demirelli M., Kara I., Sümer S., Marakoğlu K., Üzer F., Uyar Y., Çiçek T., E Ünsal Z., Vatansev H., Botan Yildirim B., Kuruoğlu T., Atilla A., Ersoy Y., Kandemir B., Durduran Y., Goksin Cihan F., Demirbaş N., Yıldırım F., Tatar D., Akcay M. S. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG) / Mycobacterium tuberculosis exposure history in healthcare workers: a multi-center study // Pathog. Glob. Health. – 2021. – Vol. 115, №. 6. – P. 405-411. https://doi.org/10.1080/20477724.2021.1927605.Torun S., Ozkaya S., Şen N., Kanat F., Karaman I., Yosunkaya S., Sengoren Dikis O., Asan A., Aydogan Eroglu S., Semih Atal S., Ayten O., Aksel N., Ermiş H., Özçelik N., Demirelli M., Kara I., Sümer S., Marakoğlu K., Üzer F., Uyar Y., Çiçek T., E Ünsal Z., Vatansev H., Botan Yildirim B., Kuruoğlu T., Atilla A., Ersoy Y., Kandemir B., Durduran Y., Goksin Cihan F., Demirbaş N., Yıldırım F., Tatar D., Akcay M.S. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG). Mycobacterium tuberculosis exposure history in healthcare workers: a multi-center study. Pathog. Glob. Health, 2021, vol. 115, no. 6, pp. 405-411. https://doi.org/10.1080/20477724.2021.1927605.Wang Y., Feng R., Xu J., Hou H., Feng H., Yang H. An updated meta-analysis on the association between tuberculosis and COVID-19 severity and mortality // J. Med. Virology. – 2021. – Vol. 93, № 10. – Р. 5682-5686. https://doi.org/10.1002/jmv.27119.Wang Y., Feng R., Xu J., Hou H., Feng H., Yang H. An updated meta-analysis on the association between tuberculosis and COVID-19 severity and mortality. J. Med. Virology, 2021, vol. 93, no. 10, pp. 5682-5686. https://doi.org/10.1002/jmv.27119.Yitbarek K., Abraham G., Girma T., Tilahun T., Woldie M. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic // Vaccine. – 2020. – Vol. 38, № 41. – P. 6374-6380. https://doi.org/10.1016/j.vaccine.2020.08.018.Yitbarek K., Abraham G., Girma T., Tilahun T., Woldie M. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Vaccine, 2020, vol. 38, no. 41, pp. 6374-6380. https://doi.org/10.1016/j.vaccine.2020.08.018.Yongang Z., Binqing F., Xiaohu Zh., Dongsheng W., Changcheng Z., Yingjie Q., Rui S., Zhigang T., Xiaoling X., Haiming W. Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+ CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus // BioRxiv. – 2020.Yongang Z., Binqing F., Xiaohu Zh., Dongsheng W., Changcheng Z., Yingjie Q., Rui S., Zhigang T., Xiaoling X., Haiming W. Aberrant pathogenic GM-CSF+T cells and inflammatory CD14+ CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus. BioRxiv, 2020.

The authors declare that there are no conflicts of interest present.